Mepanipyrim exhibited excellent disease control activity against Botrytis cinerea, but poor activity against Cochliobolus miyabeanus; however, the mycelial growth of C. miyabeanus was inhibited more strongly than that of B. cinerea. Therefore, disease control efficacy by mepanipyrim in vivo is not correlated with mycelial growth inhibition in vitro. While mepanipyrim prevented pectinase secretion in B. cinerea at 0.1-1 mg/ml, it did not interfere with secretion in C. miyabeanus, even at 100 mg/ml, indicating that its action is an important mechanism in disease control. Mepanipyrim affected the uptake of glucose and phenylalanine in the mycelia of both pathogens at higher doses. Thus, a secondary action of mepanipyrim may bring about mycelial growth inhibition in vitro.
Introduction
Mepanipyrim, N-(4-methyl-6-prop-1-ynylpyrimidin-2-yl) aniline, is an anilinopyrimidine fungicide with a broad spectrum of activity that can control fungal diseases caused by Botrytis cinerea (gray mold), Venturia spp. (scab) and Monilinia fructicola (brown rot). It also has good disease control activity against the Alternaria alternata apple pathotype (leaf spot) and the powdery mildew genera Erysiphe and Podosphaera. 1, 2) Mepanipyrim inhibits the uptake of growth substrates such as amino acids and glucose by B. cinerea at an effective dose of 10-100 mg/ml 3) and blocks the secretion of host-cell walldegrading enzymes at 1 mg/ml. The inhibition of protein secretion is the mode of action considered the most important mechanism in disease control. 4) While mepanipyrim markedly affects the infection process of B. cinerea at 1-10 mg/ml, especially germ tube elongation, secondary appressorium formation and penetration, it hardly inhibited spore germination and did not fully inhibit the mycelial growth of B. cinerea. 1, 3) Taking advantage of its strong inhibition against germ tube elongation instead of weakly mycelial growth inhibition, the FGA-paper disc method 5) can evaluate the sensitivity of B. cinerea to mepanipyrim. In addition, assay qualities of the FGA-paper disc method were improved to use gelatin in the medium, resulting in utilizing the inhibitory activity of mepanipyrim in protease secretion.
The in vitro fungicidal activities of many compounds correspond to disease control in vivo. Polyoxin interferes with cell wall chitin biosynthesis 6) but does not affect Oomycete fungi, which do not have chitin as a cell wall component. Although the selective mechanism that determines which fungi are sensitive has not been fully characterized, mepronil can control Basidiomycete diseases, and its inhibitory activity in vitro is restricted to the Basidiomycetes. 7) Benthiavalicarb-isopropyl is effective against all Oomycete plant pathogens except Pythium spp. both in vitro and in vivo. 8) With the notable exception of non-fungicidal protectants such as probenazole 9, 10) and tricyclazole, 11) the disease control efficacy of a fungicide can generally be predicted from its inhibitory activity against mycelia or spores of plant pathogens. Mepanipyrim, however, strongly affects fungal diseases caused by B. cinerea despite the weak inhibition of spore germination and mycelial growth in vitro. 1, 3) The in vitro antifungal activity of mepanipyrim thus does not accurately reflect disease control efficacy in vivo.
This paper provides the first suggestion of the selectivity of mepanipyrim for various plant pathogens in disease control and gives some evidence of the possible modes of action.
Materials and Methods

Chemicals and fungal cultures
Mepanipyrim was provided as a reagent grade product by Ihara Chemical Industry Co., Ltd. (Tokyo, Japan). A stock solution of mepanipyrim (2000-20,000 mg/ml) was prepared in methanol and diluted appropriately for each assay. A 40% suspension concentrate formulation (Frupica ® ) of mepanipyrim was also used for in vivo assays. B. cinerea (Kumiai stock culture No. 50-01) and Colletotrichum lagenarium (Kumiai stock culture No. 53-03) were grown and maintained on a potato-sucrose agar (PSA) plate at 20°C. Cochliobolus miyabeanus (Kumiai stock culture No. 22-01) was grown and maintained on a V-8 juice agar plate at 27°C. The culture of B. cinerea was illuminated with near-ultraviolet light (FL15B, Toshiba Lighting & Technology Co., Tokyo, Japan) for 2-3 days to induce spore formation. 
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In vivo assays
Cucumber gray mold or cucumber anthracnose (caused by C. lagenarium) was evaluated with cucumber plants (Cucumis sativus cv. Sagami-hanjiro) at the cotyledon stage grown in 9 cm pots. Test compounds were applied as a spray at 10 ml/pot. After the spray deposit had dried, the plants were inoculated with spores of the pathogens. For cucumber gray mold assay, paper discs (6 mm dia., thick type; Toyo Roshi Kaisya, Ltd., Tokyo, Japan) dipped in the spore suspension (1ϫ10 6 spores/ml, containing 0.3% yeast extract and 2% glucose) were placed on the center of cotyledons to prevent the inoculated zone from drying. The inoculated plants were transferred to a growth chamber and incubated at 20°C for 3 days (100% relative humidity). For cucumber anthracnose assay, the treated plants were sprayed with a spore suspension (2ϫ10 5 spores/ml). They were transferred to a growth chamber and incubated at 20°C for 1 day (100% relative humidity). Cucumber gray mold was assayed for lesion diameter after 3 days of inoculation, and anthracnose was assayed for the number of lesions after 6 days of inoculation. The disease control efficacy of mepanipyrim was assessed as a percentage of the means of diameters or lesion numbers in treated and untreated plants. Rice brown spot (caused by C. miyabeanus) was evaluated on rice plants (Oryza sativa Japonicum cv. Aichi-asahi) in the fourth leaf stage grown in 9 cm pots.
Fungicide application, fungal inoculation (5ϫ10 4 spores/ml, incubated at 27°C for 1 day) and disease evaluation (after 5 days of inoculation) were the same as for cucumber anthracnose. Three replications were made for each treatment.
Mycelial growth assays
Mycelial discs (4 mm in diameter) were cut from the growing edge of fungal cultures and transplanted onto PSA media containing mepanipyrim. Cultures were incubated at 20°C (B. cinerea and C. lagenarium) or 27°C (C. miyabeanus), and radial growth was measured after 3 days, 8 days, and 5 days of incubation, respectively. The inhibitory activity of mepanipyrim was assessed as a percentage of growth on control media. The reported results are the means of three replications.
Uptake of radioactive substrates
Fungal spores were suspended in Czapek liquid medium (0.3% NaNO 3 , 0.1% K 2 HPO 4 , 0.05% MgSO 4 · 7H 2 O, 0.05% KCl and 0.001% FeSO 4 · 7H 2 O, W/V) supplemented with 0.3% yeast extract and 2% glucose (C-medium), and incubated with reciprocal shaking in the absence of mepanipyrim for 24 hr at 20°C (B. cinerea and C. lagenarium) or 27°C (C. miyabeanus). Mycelia were washed three times with distilled water by centrifugation. Washed mycelia (24 mg or 26.5 mg wet weight) were suspended in Czapek medium with or without mepanipyrim. After 1 hr pre-incubation, radioactive precursors were added to give 3.7 KBq/ml. Incubation was stopped after 30 min by adding cold distilled water with the corresponding non-labeled substrates (NLS-solution) at 2.5 mM. The labeled mycelia were washed three times with NLS solution by centrifugation. They were suspended in cold 5% trichloroacetic acid (TCA) and kept on ice overnight. Major radioactivities extracted by TCA were regarded as substrates taken up by the cells. Radioactivity was measured with a liquid scintillation system (LSC-700, Aloka Co., Ltd., Tokyo, Japan) in a cocktail AQUASOL-2 (NEN Research Products). Results indicate the means of three replications.
Uptake of mepanipyrim
Fungal spores were incubated in C-medium for 24 hr at 20°C (B. cinerea and C. lagenarium) or 27°C (C. miyabeanus). Mycelia were washed three times with distilled water by centrifugation. The washed mycelia (10 mg wet weight) were suspended in Czapek liquid medium supplemented with 0.5% glucose (Czapek G medium). Radioactive isotope-labeled mepanipyrim was added to give a final concentration of 3.7 KBq/ml (1.47 mg/ml). After 60 min, incubation was stopped by adding cold distilled water and cold chased with non-labeled mepanipyrim (NLM-solution) at 10 mg/ml. The labeled mycelia were then washed three times with NLM solution by centrifugation, suspended in cold 5%TCA and kept on ice overnight. Major radioisotopic signals in TCA extracts were regarded as mepanipyrim taken up by the cells. Radioactivity was measured with a liquid scintillation system in a cocktail AQUASOL-2. Data are the means of two replications.
Pectinase secretion assays
Spores were inoculated into Czapek liquid medium supplemented with 0.5% sodium polypectate as the sole carbon source (Czapek P medium) and incubated with reciprocal shaking in the absence of mepanipyrim at 20°C (B. cinerea and C. lagenarium ) or 27°C (C. miyabeanus) for 45.5, 48 and 47 hr, respectively.
After incubation, mycelia were separated by centrifugation, and an extracellular crude enzyme solution was prepared by filtering the supernatant through a 0.45 mm cellulose membrane filter of sterilized mixed esters (Millipore Corp., Bedford, MA, USA). The assay methods of pectinase secretion were carried out according to our previous report. 4) Three replications were made for each treatment.
Results and Discussion
In vivo and in vitro activity of mepanipyrim
The in vivo disease control activity of many fungicidal compounds can be more or less accurately extrapolated from fungicidal or fungistatic assays under controlled conditions in vitro. Thus, the first aim of this study was to determine if there was any disparity between the efficacy of mepanipyrim in vivo and mycelial growth inhibition in vitro toward several plant pathogens.
Mepanipyrim completely protected plants from cucumber gray mold down to a concentration of 10 mg/ml in pot trials (Table 1) ; however, mepanipyrim was not effective in controlling cucumber anthracnose (C. lagenarium) or rice brown spot (C. miyabeanus), even at 300 mg/ml. The protective values against C. lagenarium or C. miyabeanus are too low to be practical for disease control. Although the mycelial growth of B. cinerea (16% of control) or C. lagenarium (77% of control) was inhibited to some degree by mepanipyrim, the growth of C. miyabeanus was essentially prevented at 300 mg/ml.
There are three evident responses of plant pathogenic fungi to mepanipyrim: high efficacy in vivo with weak inhibition in vitro (e.g., B. cinerea), low efficacy in vivo with weak inhibition in vitro (e.g., C. lagenarium), and low efficacy in vivo with strong inhibition in vitro (C. miyabeanus). A consistently high level of efficacy both in vivo and in vitro was not observed for any of the plant pathogens in our studies. 1) As the effectiveness of many fungicides, such as benthiavalicarb-isopropyl and mepronil, can generally be predicted from inhibitory activity in vitro, it is interesting that mepanipyrim could have unique mechanisms for mycelial growth inhibition in vitro and disease control efficacy in vivo.
Effect on uptake of radioactive substrates
Since mepanipyrim inhibits the uptake of growth substrates such as amino acids and glucose by B. cinerea, 3) the next attempt examined the uptake of these substrates to demonstrate whether uptake inhibition is related with the difference of mycelial inhibitory activity among these pathogens.
In the untreated control, there were uptake differences of amino acids and glucose among the three tested pathogens; however, preincubation with mepanipyrim resulted in the dose-responsive inhibition of glucose and phenylalanine uptake by each of the three fungi at higher doses of 10-100 mg/ml (Tables 2 and 3) , which did not correspond to either mycelial growth inhibition in vitro and disease control efficacy in vivo by mepanipyrim. Differences in uptake at higher doses suggest that the effects of mepanipyrim are nonspecific and thus unrelated to disease control modes of action.
Inhibition of nutrient import at some level could bring about chronic nutritional deficiency, resulting in mycelial growth retardation. Therefore, these inhibitions are suggested to relate to mycelial growth inhibition by mepanipyrim at a higher concentration. Mepanipyrim at 10 mg/ml exhibited 98.2% inhibition against the mycelial growth of C. miyabeanus, although the inhibition rates of the uptake of glucose and phenylalanine are 45.0% and 33.2%, respectively. Thus, the question as to why mepanipyrim more strongly inhibited mycelial growth of C. miyabeanus remained.
Uptake of mepanipyrim
Inhibiting the uptake of growth substrates by mepanipyrim did not necessarily relate to efficacy differences in vitro and in vivo among the tested pathogens; however, it remained a possibility that the amounts of mepanipyrim taken into the mycelia differed among these pathogens. To address this possibility, the uptake of 14 C-mepanipyrim into the mycelia was examined. Vol. 32, No. 2, 77-82 (2007) Biochemical basis of selective disease controlling acitivity of mepanipyrim 79 No difference was evident in the uptake of labeled mepanipyrim among B. cinerea, C. miyabeanus and C. lagenarium for 60 min incubation ( Table 4 ). The uptake of mepanipyrim in C. miyabeanus according to the incubation time from 15 min to 90 min was similar to that in B. cinerea (data not shown). The data suggested that mycelial uptake is not a critical requirement for mepanipyrim action in vivo or in vitro, while it remains to be clarified whether the difference in fungal metabolism or detoxification could affect its disease control efficacy.
Effect on pectinase secretion
Since mepanipyrim strongly inhibited pectinase secretion in B. cinerea, 4) the next attempt examined the pectinase secretion of these pathogens to demonstrate whether secretory inhibition is related with selective activity in vivo or in vitro among these pathogens.
Although mepanipyrim strongly inhibited pectinase secretion by B. cinerea, pectinase secretion by the other two fungi was either not affected, or changes were not detected because the secretion levels were near the baseline levels in the control cultures (Table 5) . This fungicide provided good protection against Botrytis, but not against Cochliobolus or Colletotrichum, a trend which is not consistent with the possible modes of action related to the uptake of either the compound itself or the nutrients glucose and phenylalanine. Only the inhibitory activity against pectinase secretion distinguished sensitive fungal pathogens from insensitive fungal pathogens in vivo.
Since B. cinerea has long been known to produce and secrete pectinase, and cause the maceration of infected tissue, [12] [13] [14] it might produce and secrete more pectinases than other pathogens. As shown in Table 5 , secreted pectinases of the untreated control by C. miyabeanus and C. lagenarium were lower than those by B. cinerea. The data suggested that pectinases and their secretion are more important for B.
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Journal of Pesticide Science cinerea than other pathogens. In our previous study, 4) mepanipyrim significantly inhibited the secretion of protease and lipase by B. cinerea. It also influenced pectinase secretion by A. alternata apple pathotype, an applicable disease for mepanipyrim. Cumulatively, it is possible that the secretory repression of proteins which contain host-cell wall-degrading enzymes for pathogenicity is an important mechanism utilized by mepanipyrim in disease control. A further investigation of the secretory inhibition of several proteins by other sensitive pathogens in vivo may shed light on the selectivity of target diseases by mepanipyrim.
Mepanipyrim specifically inhibited the secretion of pectinase in sensitive pathogens in vivo and exhibited non-specific action on various fungal pathogens by inhibiting the uptake of growth substrates. Thus, there are two possible reasons why antifungal activities in vitro are not predictive of disease control efficacy.
However, mepanipyrim hardly protected against rice brown spot (caused by C. miyabeanus) at 10-1 mg/ml, while it strongly inhibited the mycelial growth of the pathogen. The above possible reasons are assumed to not be applicable to the difference between in vitro and in vivo efficacy of C. miyabeanus; therefore, another action mechanism of mepanipyrim against inhibition in C. miyabeanus is required.
Many fungicides for gray mold, such as benzimidazole and dicarboximide fungicides, can control the diseases caused by Sclerotinia sclerotiorum, 15) but mepanipyrim did not effectively control these diseases. 1) Although mepanipyrim prevented peach scab caused by Cladosporium carpophilum, it failed to control tomato leaf mold caused by a related fungus (C. fulvum is now Fulvia fulva).
1) Mepanipyrim can thus be used to identify differences in these fungi by its controlling activity in vivo. Since the processes of protein secretion are shown to be conserved among eukaryotes, 16, 17) a mepanipyrim binding site would likely be quite specific. The next goal of our investigation is to clarify the selective mechanisms by mepanipyrim in the process of protein secretion. 
